J Stroke.  2021 Jan;23(1):139-143. 10.5853/jos.2020.05043.

Health Economic Impact of First Pass Success: An Asia-Pacific Cost Analysis of the ARISE II Study

• Yeo L
• Zaidat OO
• Saver JL
• Mattle HP
• Lee SHY
• Kottenmeier E
• Cameron HL
• Qadeer RA
• Andersson T

• KMID: 2512365
• DOI: http://doi.org/10.5853/jos.2020.05043

Figure

• 

  Figure 1. Estimated per-patient procedural and hospitalization-related healthcare use cost savings for the first pass effect (FPE) and non-FPE groups. Negative values represent cost savings for patients in the FPE group as compared with the non-FPE group. Numbers may not sum due to rounding. AUD, Australian dollar; INR, Indian rupee; SGD, Singapore dollar; TWD, Taiwan dollar; LOS, length of stay; USD, United States dollar. *Reported as charges; †Reported as 2019 USD for Singapore. Exchange rates reported for June 22, 2020 16:00 Coordinated Universal Time (UTC) were used for all countries. The exchange rates were as follows: 1.00 AUD:0.69 USD; 1.00 INR:0.01 USD; 1.00 JPY:0.01 USD; 1.00 ₩:0.001 USD; 1.00 SGD:0.72 USD; and 1.00 TWD:0.03 USD.

• 

  Figure 2. Estimated per-patient long-time care cost savings, based on 90-day modified Rankin Scale (mRS), for the first pass effect (FPE) and non-FPE groups. Negative values represent cost savings for patients in the FPE group as compared with the non-FPE group. Numbers may not sum due to rounding. AUD, Australian dollar; INR, Indian rupee; USD, United States dollar. *Reported for India and South Korea but not used for analyses to ensure consistency with other countries that did not report a cost for death (i.e., mRS 6); †Exchange rates reported for June 22, 2020 16:00 Coordinated Universal Time (UTC) were used for all countries. The exchange rates were as follows: 1.00 AUD:0.69 USD; 1.00 INR:0.01 USD; 1.00 JPY:0.01 USD; and 1.00 ₩:0.001 USD.

Reference

References

1. Zaidat OO, Castonguay AC, Linfante I, Gupta R, Martin CO, Holloway WE, et al. First pass effect: a new measure for stroke thrombectomy devices. Stroke. 2018; 49:660–666.

2. Zaidat OO, Bozorgchami H, Ribó M, Saver JL, Mattle HP, Chapot R, et al. Primary results of the multicenter ARISE II study (Analysis of Revascularization in Ischemic Stroke With EmboTrap). Stroke. 2018; 49:1107–1115.

3. Dawson J, Lees JS, Chang TP, Walters MR, Ali M, Davis SM, et al. Association between disability measures and healthcare costs after initial treatment for acute stroke. Stroke. 2007; 38:1893–1898.

4. Lobotesis K, Veltkamp R, Carpenter IH, Claxton LM, Saver JL, Hodgson R. Cost-effectiveness of stent-retriever thrombectomy in combination with IV t-PA compared with IV t-PA alone for acute ischemic stroke in the UK. J Med Econ. 2016; 19:785–794.

5. Kunz WG, Almekhlafi MA, Menon BK, Saver JL, Hunink MG, Dippel DWJ, et al. Public health and cost benefits of successful reperfusion after thrombectomy for stroke. Stroke. 2020; 51:899–907.

6. Maegerlein C, Berndt MT, Mönch S, Kreiser K, Boeckh-Behrens T, Lehm M, et al. Further development of combined techniques using stent retrievers, aspiration catheters and BGC: The PROTECTPLUS Technique. Clin Neuroradiol. 2020; 30:59–65.

7. Delgado Almandoz JE, Kayan Y, Young ML, Fease JL, Scholz JM, Milner AM, et al. Comparison of clinical outcomes in patients with acute ischemic strokes treated with mechanical thrombectomy using either Solumbra or ADAPT techniques. J Neurointerv Surg. 2016; 8:1123–1128.